Sunday April 05, Barcelona
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Fragility fractures in Sub-Saharan Africa: Time to break the myth!
Chairperson: ‣ Celia L. Gregson
‣ Chairs introduction and setting the scene Celia L. Gregson
‣ Trends in fracture incidence in high-income countries Bo Abrahamsen
‣ Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? Kate Ward
‣ Panel discussion
‣ Summary and wrap-up Celia L. Gregson
DENOSUMAB discontinuation: Trends, challenges, ups-and-downs
Chairperson: ‣ Bruno Muzzi Camargos
‣ Vertebral Fracture Following D-Mab Discontinuation: Supporting Data Oscar Rosero Olarte
‣ Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana Medina Orjuella
‣ Biochemichal And Imaging Assessment: Ups And Downs Bruno Muzzi Camargos
‣ Bone Loss After D-Mab Discontinuation In 150 Patients Maria Belen Zanchetta
‣ D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot Luis Fernando Vidal Neira
When a DXA is indicated, a VFA is also recommended
Chairpersons: ‣ Willem Lems, ‣ Kristina Åkesson
‣ Introduction Willem Lems
‣ Clinical relevance of vertebral fractures Julien Paccou
‣ Radiological diagnosis of vertebral fractures with VFA Jean Zhang
‣ Advantages and limitations of VFA Manju Chandran
‣ Discussion Kristina Åkesson
Behavioral strategies for the busy clinician
Chairperson: ‣ Daniel Pinto
‣ Go With The flow: Remembering Your Patients Are Human Julie Miller
‣ Using A Brief Motivational Interviewing Approach in Rheumatology Practice Steven Cole
‣ The Development of Electronic Brief Action Planning Daniel Pinto
Female Bone Health: a gynecological approach on women's special conditions
Chairperson: ‣ Adriana Orcesi Pedro
‣ Opening Adriana Orcesi Pedro
‣ Update on management of low bone mass in young women Adriana Orcesi Pedro
‣ Bone mass and fracture risk during pregnancy and lactation Ben‑Hur Albergaria
‣ Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors Marcelo Luis Steiner
‣ Question & Answers with audience
Sarcopenic obesity
Chairperson: ‣ Ifigenia Kostoglou‑Athanassiou
‣ Sarcopenia. Diagnosis and evaluation Panagiotis Athanassiou
‣ Sarcopenia and nutrition Lambros Athanassiou
‣ Sarcopenic obesity. Definition and pathophysiology Ifigenia Kostoglou‑Athanassiou
‣ Sarcopenic obesity. Management Yannis Dionyssiottis
‣ Discussion
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty
Chairperson: ‣ Dominique Verté
‣ Introduction Ivan Bautmans
‣ Towards a uniform language of Frailty Roberta Vella‑Azzopardi
‣ Fatigue in the frailty constructs Veerle Knoop
‣ The disability paradox in the frailty constructs Axelle Costenoble
‣ Measures of cognition in the frailty constructs Mirko Petrovic
‣ Discussion
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESPRM-ESCEO-IOF Joint Session
Fibromyalgia : An evidence-based approach for diagnosis and management
Chairperson: ‣ Fitnat Dincer
‣ Update in Diagnosis of Fibromyalgia on the basis of Evidence Based Medicine Andreas Winkelman
‣ Update in Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Fitnat Dincer
‣ Update in Non-Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Raquel Valero, Susana Munoz
08.00 - 09.00
Educational Lecture
‣ Management of hyperparathyroidism in chronic kidney disease
‣ Pierre Delanaye
08.00 - 09.00
SICOT-ESCEO-IOF Symposium: Fracture Liaison Services (FLS) in Orthopaedic Surgery
Chairpersons: ‣ Josée Delisle, ‣ Philippe Halbout
‣ Opening message Philippe Halbout, Josée Delisle
‣ Success story of collaboration between orthopaedics and rest of the world in FLS! How can I work with my orthopaedic surgeon? Julio Fernandes
‣ Getting FLSs sustainable - key steps Kassim Javaid
‣ Teams and empowerment! How to create synergy between the Nurse, Doctor, Family and the Patient? Josée Delisle
‣ Crossfire and Q&A
‣ Closing message Josée Delisle
08.00 - 09.00
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Nicholas R. Fuggle
‣ Welcome and scope of the problem Adolfo Diez‑Perez
‣ Assessment of cardio-vascular safety of Calcium and Vitamin D Nicholas Harvey
‣ Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs Santiago Palacios
‣ Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis René Rizzoli
‣ Discussion (Leader: Santiago Palacios): All participants of the Working Group
‣ Conclusions Nicholas R. Fuggle
Panel: ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Cyrus Cooper, ‣ Elaine M. Dennison, ‣ Adolfo Diez‑Perez, ‣ Nicholas R. Fuggle, ‣ Nicholas Harvey, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Santiago Palacios, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Serge Rozenberg, ‣ Thierry Thomas, ‣ Florence Trémollières
09.00 - 10.00
Poster Viewing Session III
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Bone and joints in intense competition sport : lesson for the practice ?
‣ Jean‑François Kaux
Bariatric surgery, bone and joints
‣ Daniel Prieto‑Alhambra
Androgens, bone and muscles
‣ Jean‑Marc Kaufman
Efficacy and cost/benefit of FLS
‣ Radmila Matijevic
High Bone Mass: What are the causes and how should we manage it?
‣ Celia L. Gregson
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
‣ Andreas Kurth
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: ‣ Famida Jiwa, ‣ Serge Ferrari
10.00
Plenary Lecture 9
‣ Rare bone diseases : what do they teach us for musculoskeletal disorders management Kassim Javaid
10.30
Presentation of the ESCEO-IOF Young Investigator Awards
‣ Cyrus Cooper
10.40
Oral communication selected from abstracts
11.30
Plenary Lecture 10
‣ Strategies to fill the Treatment Gap in Osteoporosis: place of Combination and Sequential Regimens Manju Chandran
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Osteosarcopenia school
Chairpersons: ‣ Mark Lissens, ‣ Yannis Dionyssiotis
‣ Osteosarcopenia Ifigenia Kostoglou‑Athanassiou
‣ Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients Mark Lissens
‣ Osteosarcopenia school Yannis Dionyssiotis
‣ Discussion
Clinical diagnostics of chronic and acute pain. Multimodal approach
Chairperson: ‣ Olga Kurushina
‣ Acute and chronic pain: The difference between diagnostic approaches Olga Kurushina
‣ Pain and biomechanics Alexander Barulin
‣ Features of clinical diagnosis of cervicogenic headache Anna Drushlyakova
‣ Diagnosis of temporomandibular disorders in patients with chronic facial pain Bogdan Kalinchenko
Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients
Chairpersons: ‣ Pinar Borman, ‣ Vesile Sepici
‣ The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients Belgin Karaoglan
‣ The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores Pinar Borman
‣ Laboratory overview of bone turnover markers Aylin Sepici Dincel
‣ Risk Factors of osteoporosis and osteoporotic fractures Vesile Sepici
Controversies regarding the management of gout and asymptomatic hyperuricemia
Chairperson: ‣ Razvan Adrian Ionescu
‣ Uric acid - Friend or foe? Mihai Bojinca
‣ Asymptomatic hyperuricemia - The hidden realm (Imaging clue) Florentin Ananu Vreju
‣ Bone mineral density in hyperuricemia and gout - Collateral damage? Claudiu Avram
‣ Gout treatment - As easy as it seems? Razvan Adrian Ionescu
The microcirculation abnormalities in osteoporosis and osteoarthritis
Chairpersons: ‣ Sekib Sokolovic, ‣ Alena Rudenko
‣ Introduction Sekib Sokolovic
‣ Angiogenesis and Bone Gerold Holzer
‣ Vascular pathology and Osteoarthritis, Imaging of Microcirculation Juan Jose Scali
‣ The Microcirculation abnormalities in Osteoporosis and Osteoarthritis Sekib Sokolovic
‣ Discusion and Closing remarks
Non-pharmacological approaches in the management of osteoporosis
Chairperson: ‣ Yesim Gokce Kutsal
‣ How to modify life-style? Yesim Gokce Kutsal
‣ The role of exercises: What type of exercise when? Jale Meray
‣ Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? Ayse A. Kucukdeveci
‣ Case presentations Yesim Kirazli
Relevance of body composition in chronic diseases
Chairperson: ‣ Mislav Radić
‣ Association of body composition with disease activity in rheumatoid arthritis Mislav Radić
‣ Relationship of body composition with osteoporosis Tonko Vlak
‣ Impact of disability on body composition in multiple sclerosis Ozren Polasek
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study
Chairperson: ‣ Dominique Verté
‣ Introduction Ivan Bautmans
‣ General profile of the Butterfly participants Aziz Debain
‣ Validated equations for estimating body composition in the oldest old Jona Van den Broeck
‣ Immunosenescence signatures in pre-frailty Rose Njemini
‣ Discussion
